Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8393379)

  • 1. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
    Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Evans SR
    Cancer Res; 1993 Aug; 53(16):3712-8. PubMed ID: 8393379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
    Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
    Evans SR; Houghton AM; Schumaker L; Brenner RV; Buras RR; Davoodi F; Nauta RJ; Shabahang M
    J Surg Res; 1996 Feb; 61(1):127-33. PubMed ID: 8769954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
    López-Boado YS; Puente XS; Alvarez S; Tolivia J; Binderup L; López-Otín C
    Cancer Res; 1997 Sep; 57(18):4091-7. PubMed ID: 9307298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
    Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
    Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR; Schwartz AM; Shchepotin EI; Uskokovic M; Shchepotin IB
    Clin Cancer Res; 1998 Nov; 4(11):2869-76. PubMed ID: 9829754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation.
    Kondoh N; Schweinfest CW; Henderson KW; Papas TS
    Cancer Res; 1992 Feb; 52(4):791-6. PubMed ID: 1339304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.
    Franceschi RT; James WM; Zerlauth G
    J Cell Physiol; 1985 Jun; 123(3):401-9. PubMed ID: 2985632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vitamin D3 receptor mRNA in the proliferation of hepatocellular carcinoma.
    Miyaguchi S; Watanabe T
    Hepatogastroenterology; 2000; 47(32):468-72. PubMed ID: 10791215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer.
    Cross HS; Bajna E; Bises G; Genser D; Kállay E; Pötzi R; Wenzl E; Wrba F; Roka R; Peterlik M
    Anticancer Res; 1996; 16(4B):2333-7. PubMed ID: 8694565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y; Knutson JC; Bishop C; Shany S
    Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the content of 1,25-dihydroxyvitamin D3 receptors in digestive mucosa and adenocarcinoma].
    Meggouh F; Lointier P; Pezet D; Saez S
    Bull Cancer; 1990; 77(3):205-12. PubMed ID: 2160306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between the concentration of 1,25 alpha dihydroxyvitamin D3 receptors and growth inhibition, and differentiation of human osteosarcoma cells induced by vitamin D3].
    Tokuumi Y
    Nihon Seikeigeka Gakkai Zasshi; 1995 Apr; 69(4):181-90. PubMed ID: 7782656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1 alpha,25-Dihydroxyvitamin D3 induces anchorage-independent growth and c-Ki-ras expression of BALB/3T3 and NIH/3T3 cells.
    Huh N; Satoh M; Nose K; Abe E; Suda T; Rajewsky MF; Kuroki T
    Jpn J Cancer Res; 1987 Feb; 78(2):99-102. PubMed ID: 3030988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
    Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ
    Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth.
    Tong WM; Hofer H; Ellinger A; Peterlik M; Cross HS
    Oncol Res; 1999; 11(2):77-84. PubMed ID: 10489163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro.
    Lointier P; Wargovich MJ; Saez S; Levin B; Wildrick DM; Boman BM
    Anticancer Res; 1987; 7(4B):817-21. PubMed ID: 2823686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific receptors for 1,25-dihydroxyvitamin D3 (1,25-DR) and human colorectal carcinogenesis.
    Lointier P; Meggouh F; Pezet D; Dapoigny M; Dieng PN; Saez S; Chipponi J
    Anticancer Res; 1989; 9(6):1921-4. PubMed ID: 2560626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.